GI Tumors Flashcards

1
Q

GIST

A

c-KIT (85%)

PDGFRA (5-10%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Juvenile polyp/syndrome

A

Auto dom
SMAD4 (20%)
BMPR1A (20%)-> both involve TGF beta signalling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Peutz-Jeghers polyps/syndrome

A

Auto dom: STK11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cowden syndrome

A

Auto dom: PTEN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cronkhite-Canada

A

Non-hereditary; likely autoimmune

*Ectodermal abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Sessile Serrated

A

BRAF V600E mutations
Methylation of tumor suppresor gene- shut down
MSI (+/-)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Colorectal carcinoma - Adenocarcinoma sequence

A

Adenoma-carcinoma sequence: Normal colon -> Loss of APC/beta-catenin gene -> mucosa at risk -> K-RAS mutation -> adenoma -> loss of p53 -> carcinoma -> telomerase

> 80% of CRC have inactivated APC, many w/out APC mutation have beta-catenin mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Familial Adenomatous Polyposis (FAP)

A

Auto. dominant APC mutation (chromo 5)-> proximal mutation near N terminus, less APC gene made -> no residual function ; 25% have no FamHx -> new, de novo mutations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Attenuated FAP

A

Mutation closer to C terminus, longer protein made so some residual APC activity is present -> mutation weakens APC but doesnt completely knock it out which is why you get less polyps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

MYH associated polyposis (MAP)

A

auto. recessive mutation in MYH gene (chromo 1); MYH = DNA repair protein (base excision repair)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lynch syndrome/ Hereditary Nonpolyposis Colorectal cancer

A

auto. dom. mutation in DNA mismatch repair gene; MSI pathway
NO BRAF mutations in Lynch syndrome; 68% of sporadic MSI CRC have BRAF mutation

  • MSH2/MSH6 find mutation
  • MLH1/PMS2 repair it

MSH2 holds onto MSH6
- MSH2 knockout (KO) also KOs MSH6
MLH1 holds onto PMS2
- MLH1 KO also KOs PMS2

Mutations in MSH2, MSH6 or PMS2 = Lynch
- However MLH1 mutation could be sporadic or Lynch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
Neuroendocrine tumor, secretes bioactive compounds
Elevated serotonin (5-HT) 5-HIAA
A

Carcinoid tumor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Two types of intestinal polyps. Which is easier to remove?

A

Pedunculate and sessile polyps

*Pedunculated is easier to remove

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Benign tumor, focal mass (resembles tumor), d/t development error
Mature, histo normal elements -> growing in disorganized manner

A

Hamartomatous polyps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pedunculated, 1-3 cm (large); Kids < 5 y.o., 80% in rectum

Expanded lamina propria (LP) w/ variable inflammation, abundant cystically dilated glands glassy, mucousy appearance

A

Juvenile polyps/syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Large & pedunculated

Syndrome -> multiple polyps, hyperpigm of mucosa (mouth) & cutaneous (fingers), incr risk of intussusception & ca of pancr, breast, lung, ovary, uterus

CT and smooth muscle extends into polyp

A

Peutz-Jehgers Polyps/syndrome

17
Q

Hamartomatous polyp

Facial trichilemmomas, oral papillomas, acral keratoses
Assoc. risk of thyroid & breast ca

A

Cowden Syndrome

18
Q

Pseudopolyps -> regenerating mucosa adjacent to ulceration (severe IBD)

A

Inflammatory Polyps

19
Q

Mucosal bumps caused by intramucosal lymphoid follicles -normal

A

Lymphoid Polyps

20
Q

SMALL (1/2 in rectosigmoid colon

A

Serrated Polyps

21
Q

Majority (60-90%), no malignant potential

Grows from base of crypt. Only see serations at the ends (near the lumen) .

Distal colon

A

Hyperplastic polyps

22
Q

10-30%, HIGH MALIGNANT potential

“Interval tumor” (arise in-betw colonoscopies). These polyps were either missed or thought to be hyperplastic polyps on initial colonoscopy -> so they were never removed. Before next coloscopy they became dysplastic and eventually a cancerous mass.

Grows in middle of crypt (can see dilation at crypt base)

Proximal colon

A

Sessile serrated polyps

23
Q

Arise d/t epith proliferative dysplasia, Precursor lesion for adenocarcinoma

Asymptomatic or present w/ rectal bleeding or anemia
Intramucosal carcinoma -> invades LP, no metastatic potential; invasive when goes thru muscularis mucosa

A

Adenomatous polyps

24
Q

Three types of adenomatous polyps

A

Tubular
Villous
Tubulovillous

25
Tubular glands, often small, pedunculated, single or multiple, rare >2.5 cm Dysplastic epithelium -> elongated, pseudostratified, hyperchromatic nuclei w' loss of mucin production. stain darker, no mucin production, haphazard gland arrangement. 90% in colon
Tubular polyp
26
Villious projections, often large (up to 10cm dia), sessile Most common in older ppl w/ rectosigmoid colon; risk of cancer 40% if adenoma >4 cm more invasive potential simply because they are located more closely to lympathics (sessile so no stalk to buffer the invasive cells)
Villous polyp
27
Treatment for tubular vs villous polyp
Tubular = Endoscopic removal adequate if negative resection margins and no vascular/ lymph involvement. Villous = Endoscopic removal INADEQUATE -> colectomy.
28
Right sided presentation of CRC
Right-sided: fatigue, weakness, iron deficiency anemia, polypoid exophytic lesions, occult blood
29
Left sided presentation of CRC
Left-sided: occult bleeding/hematochezia, change bowel habits, abd discomfort, annular "napkin ring/apple core" constrictions
30
What is the most common location of CRC?
Rectosigmoid > cecum/ascending > descending; difficult to identify grossly hence go unnoticed until it is a carcinoma
31
Treatment options of CRC
Anti-EGFR (ie Cetuximab, panitumumab, bevacizumab); but K-Ras mutation = negative predictor of EGFR MOAB therapy (b/c downstream of target antibody); BRAF mutation correlates w/ poor prognosis and lack of response
32
Treatment for Familial Adenomatous Polyposis
Prophylactic colectomy
33
FAP + osteomas, epidermoid cysts, desmoid tumors
Gardener's Syndrome
34
FAP + medulloblastoma
Turcot's Syndrome
35
Treatment for Lynch Syndrome
Resection of course. Then.... MSS & MSI-L are treated the same way. It is beneficial to use 5FU adjuvant chemotherapy. MSI-H do not do well when treated with 5FU adjuvant chemotherapy so dont treat them with this!
36
Lynch syndrome + sebaceous adenomas/carcinomas, & keratocanthomas
Muir-Torre Syndrome
37
Tumors of the appendix
Mucocele: obstructed appendix containing mucin (not truly a tumor) Mucinous cystadenoma/cystadenocarcinoma: mucous secreting epithelial tumor; associated with diverticular formation